{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:14:34Z","timestamp":1784402074098,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s10067-025-07850-w","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T18:44:47Z","timestamp":1764701087000},"page":"559-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The utility of rituximab in patients with eosinophilic fasciitis: case series from an Australian tertiary multidisciplinary clinic"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4103-6953","authenticated-orcid":false,"given":"Syed B.","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Marshman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Newland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Goldblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"issue":"12","key":"7850_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s11926-017-0700-6","volume":"19","author":"DR Mazori","year":"2017","unstructured":"Mazori DR, Femia AN, Vleugels RA (2017) Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep 19(12):74. https:\/\/doi.org\/10.1007\/s11926-017-0700-6","journal-title":"Curr Rheumatol Rep"},{"key":"7850_CR2","first-page":"70","volume":"88","author":"LE Shulman","year":"1975","unstructured":"Shulman LE (1975) Diffuse fasciitis with eosinophilia: a new syndrome? Trans Assoc Am Physicians 88:70\u201386","journal-title":"Trans Assoc Am Physicians"},{"issue":"4","key":"7850_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00296-025-05826-2","volume":"45","author":"O Hamdan","year":"2025","unstructured":"Hamdan O, Alshajrawi R, Mussa Q, Alajlouni Y, Dabbah Y, Fratekh R et al (2025) Characteristics and factors associated with treatment response among patients with eosinophilic fasciitis: a systematic review and meta-analysis. Rheumatol Int 45(4):71. https:\/\/doi.org\/10.1007\/s00296-025-05826-2","journal-title":"Rheumatol Int"},{"issue":"2","key":"7850_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/bjd.16535","volume":"179","author":"L Spielmann","year":"2018","unstructured":"Spielmann L, Arnaud L, Severac F, Messer L, Mah\u00e9 A, Meyer A et al (2018) Population-based prevalence of eosinophilic fasciitis (Shulman syndrome): a capture-recapture study. Br J Dermatol 179(2):516\u2013517. https:\/\/doi.org\/10.1111\/bjd.16535","journal-title":"Br J Dermatol"},{"key":"7850_CR5","doi-asserted-by":"publisher","unstructured":"Mazilu D, Bolta\u0219iu T\u0103taru LA, Mardale DA, Bij\u0103 MS, Ismail S, Zanfir V, et al (2023) Eosinophilic Fasciitis: Current and Remaining Challenges. Int J Mol Sci 24(3). https:\/\/doi.org\/10.3390\/ijms24031982","DOI":"10.3390\/ijms24031982"},{"issue":"5","key":"7850_CR6","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1093\/rheumatology\/keac526","volume":"62","author":"D Pehl","year":"2023","unstructured":"Pehl D, Preu\u00dfe C, Allenbach Y, Benveniste O, Dittert P, Alten R et al (2023) Eosinophilic fasciitis (Shulman syndrome)-recognition of the histological spectrum allows for new insights into possible pathomechanisms. Rheumatology (Oxford) 62(5):2005\u20132014. https:\/\/doi.org\/10.1093\/rheumatology\/keac526","journal-title":"Rheumatology (Oxford)"},{"issue":"4\u20135","key":"7850_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.autrev.2014.01.019","volume":"13","author":"I Pinal-Fernandez","year":"2014","unstructured":"Pinal-Fernandez I, Selva-O\u2019 Callaghan A, Grau JM (2014) Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 13(4\u20135):379\u2013382. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.019","journal-title":"Autoimmun Rev"},{"issue":"8","key":"7850_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/1346-8138.14160","volume":"45","author":"M Jinnin","year":"2018","unstructured":"Jinnin M, Yamamoto T, Asano Y, Ishikawa O, Sato S, Takehara K et al (2018) Diagnostic criteria, severity classification and guidelines of eosinophilic fasciitis. J Dermatol 45(8):881\u2013890. https:\/\/doi.org\/10.1111\/1346-8138.14160","journal-title":"J Dermatol"},{"issue":"8","key":"7850_CR9","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/ijd.17809","volume":"64","author":"M Huynh","year":"2025","unstructured":"Huynh M, Bogdanski E, Fleshman T, Schneider J, Libson K, Werth VP et al (2025) Eosinophilic fasciitis: new developments and future directions. Int J Dermatol 64(8):1356\u20131370. https:\/\/doi.org\/10.1111\/ijd.17809","journal-title":"Int J Dermatol"},{"key":"7850_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246151","author":"A Primitivo","year":"2021","unstructured":"Primitivo A, Madeira N, Lopez D, Afonso D (2021) Eosinophilic fasciitis (Shulman disease) with clinical, imaging and pathological correlation. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2021-246151","journal-title":"BMJ Case Rep"},{"issue":"3","key":"7850_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s12016-017-8625-4","volume":"53","author":"C Ferreli","year":"2017","unstructured":"Ferreli C, Gasparini G, Parodi A, Cozzani E, Rongioletti F, Atzori L (2017) Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 53(3):306\u2013336. https:\/\/doi.org\/10.1007\/s12016-017-8625-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"7850_CR12","doi-asserted-by":"publisher","first-page":"1180221","DOI":"10.3389\/fimmu.2023.1180221","volume":"14","author":"C Bobeica","year":"2023","unstructured":"Bobeica C, Niculet E, Craescu M, Parapiru EL, Corduneanu-Luca AM, Debita M et al (2023) Immunologic and nonimmunologic sclerodermal skin conditions - review. Front Immunol 14:1180221. https:\/\/doi.org\/10.3389\/fimmu.2023.1180221","journal-title":"Front Immunol"},{"issue":"4","key":"7850_CR13","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","volume":"26","author":"D Lebeaux","year":"2012","unstructured":"Lebeaux D, S\u00e8ne D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26(4):449\u2013458. https:\/\/doi.org\/10.1016\/j.berh.2012.08.001","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"7850_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3329\/jhpn.v30i1.11292","volume":"30","author":"MN Islam","year":"2012","unstructured":"Islam MN, Islam MA, Abdal SJ, Azad MA, Ahmedullah AK, Haq SA (2012) Eosinophilic fasciitis: what matters in management in a developing country\u2013a case report with two and a half-year follow-up. J Health Popul Nutr 30(1):117\u2013120. https:\/\/doi.org\/10.3329\/jhpn.v30i1.11292","journal-title":"J Health Popul Nutr"},{"issue":"3","key":"7850_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.jaad.2017.05.018","volume":"77","author":"JS Mertens","year":"2017","unstructured":"Mertens JS, Thurlings RM, Kievit W, Seyger MMB, Radstake TRD, de Jong E (2017) Long-term outcome of eosinophilic fasciitis: A cross-sectional evaluation of 35 patients. J Am Acad Dermatol 77(3):512\u20137.e5. https:\/\/doi.org\/10.1016\/j.jaad.2017.05.018","journal-title":"J Am Acad Dermatol"},{"key":"7850_CR16","doi-asserted-by":"publisher","unstructured":"Bestavros S, Huang RS, Shenouda C, McMullen EP, Khosravi-Hafshejani T (2025) Treatment Outcomes of Eosinophilic Fasciitis: A Systematic Review. J Cutan Med Surg 12034754251338831. https:\/\/doi.org\/10.1177\/12034754251338831","DOI":"10.1177\/12034754251338831"},{"issue":"1","key":"7850_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-4632.2007.03544.x","volume":"47","author":"L Bischoff","year":"2008","unstructured":"Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47(1):29\u201335. https:\/\/doi.org\/10.1111\/j.1365-4632.2007.03544.x","journal-title":"Int J Dermatol"},{"issue":"1","key":"7850_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/jamadermatol.2015.3648","volume":"152","author":"NA Wright","year":"2016","unstructured":"Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA (2016) Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol 152(1):97\u201399. https:\/\/doi.org\/10.1001\/jamadermatol.2015.3648","journal-title":"JAMA Dermatol"},{"issue":"3","key":"7850_CR19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/1756-185X.14284","volume":"25","author":"S Watanabe","year":"2022","unstructured":"Watanabe S, Kondo M, Ichishi M, Hayashi A, Matsushima Y, Hirokawa Y et al (2022) Eosinophilic fasciitis induced by a game of drumming probably via type 2 innate immunity. Int J Rheum Dis 25(3):364\u2013366. https:\/\/doi.org\/10.1111\/1756-185X.14284","journal-title":"Int J Rheum Dis"},{"key":"7850_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jdin.2023.01.011","volume":"11","author":"S Chohan","year":"2023","unstructured":"Chohan S, Wong N, Hanson J, Osto M, Daveluy S (2023) Eosinophilic fasciitis may present as a paraneoplastic syndrome of hematological malignancies-a systematic review. JAAD Int 11:85\u201387. https:\/\/doi.org\/10.1016\/j.jdin.2023.01.011","journal-title":"JAAD Int"},{"issue":"6","key":"7850_CR21","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.jaad.2021.05.030","volume":"86","author":"A Teboul","year":"2022","unstructured":"Teboul A, Chouchana L, Durrieu G, Eftekhari P, Treluyer JM, Mouthon L et al (2022) Drug-induced eosinophilic fasciitis: a dual pharmacovigilance analysis. J Am Acad Dermatol 86(6):1372\u20131375. https:\/\/doi.org\/10.1016\/j.jaad.2021.05.030","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"7850_CR22","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0049-0172(88)90008-x","volume":"17","author":"S Lakhanpal","year":"1988","unstructured":"Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB (1988) Eosinophilic fasciitis: clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17(4):221\u2013231. https:\/\/doi.org\/10.1016\/0049-0172(88)90008-x","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"7850_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-025-03574-z","volume":"27","author":"X Wang","year":"2025","unstructured":"Wang X, Zhang L, Hou Y, Dai T, Ma X, Shao K et al (2025) Clinicopathological profile of eosinophilic fasciitis: a retrospective cohort study from a neuromuscular disorder center in China. Arthritis Res Ther 27(1):110. https:\/\/doi.org\/10.1186\/s13075-025-03574-z","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"7850_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/rhu.0000000000000524","volume":"23","author":"R Fruchter","year":"2017","unstructured":"Fruchter R, Mazori DR, Femia AN (2017) Groove sign of eosinophilic fasciitis. J Clin Rheumatol 23(3):169. https:\/\/doi.org\/10.1097\/rhu.0000000000000524","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"7850_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5152\/eurjrheum.2019.19051","volume":"7","author":"RR Kumar","year":"2020","unstructured":"Kumar RR, Kumar U (2020) Groove sign: Heeding clue to eosinophilic fasciitis. Eur J Rheumatol 7(1):52. https:\/\/doi.org\/10.5152\/eurjrheum.2019.19051","journal-title":"Eur J Rheumatol"},{"issue":"12","key":"7850_CR26","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.revmed.2017.07.010","volume":"38","author":"V Ernest","year":"2017","unstructured":"Ernest V, Sautereau N, Masson E, Chemouni D, Garcia M, Bertolino J et al (2017) Eosinophilia heralding the diagnosis of eosinophilic fasciitis (Shulman\u2019s disease). Rev Med Interne 38(12):840\u2013843. https:\/\/doi.org\/10.1016\/j.revmed.2017.07.010","journal-title":"Rev Med Interne"},{"issue":"1","key":"7850_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jaad.2017.06.148","volume":"78","author":"O Onajin","year":"2018","unstructured":"Onajin O, Wieland CN, Peters MS, Lohse CM, Lehman JS (2018) Clinicopathologic and immunophenotypic features of eosinophilic fasciitis and morphea profunda: a comparative study of 27 cases. J Am Acad Dermatol 78(1):121\u2013128. https:\/\/doi.org\/10.1016\/j.jaad.2017.06.148","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"7850_CR28","first-page":"75","volume":"28","author":"JF Viallard","year":"2001","unstructured":"Viallard JF, Taupin JL, Ranchin V, Leng B, Pellegrin JL, Moreau JF (2001) Analysis of leukemia inhibitory factor, type 1 and type 2 cytokine production in patients with eosinophilic fasciitis. J Rheumatol 28(1):75\u201380","journal-title":"J Rheumatol"},{"issue":"7886","key":"7850_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41586-021-04044-7","volume":"599","author":"IC Boothby","year":"2021","unstructured":"Boothby IC, Kinet MJ, Boda DP, Kwan EY, Clancy S, Cohen JN et al (2021) Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin. Nature 599(7886):667\u2013672. https:\/\/doi.org\/10.1038\/s41586-021-04044-7","journal-title":"Nature"},{"issue":"2","key":"7850_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12016-015-8485-8","volume":"50","author":"H Long","year":"2016","unstructured":"Long H, Zhang G, Wang L, Lu Q (2016) Eosinophilic skin diseases: a comprehensive review. Clin Rev Allergy Immunol 50(2):189\u2013213. https:\/\/doi.org\/10.1007\/s12016-015-8485-8","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"7850_CR31","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.jacig.2024.100346","volume":"3","author":"G Thompson","year":"2024","unstructured":"Thompson G, Ali S, Trevenen M, Vlaskovsky P, Murray K, Lucas M (2024) Distinguishing DRESS syndrome from drug rash and eosinophilia: beyond RegiSCAR criteria. J Allergy Clin Immunol: Glob 3(4):100346. https:\/\/doi.org\/10.1016\/j.jacig.2024.100346","journal-title":"J Allergy Clin Immunol: Glob"},{"issue":"5","key":"7850_CR32","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaad.2022.08.026","volume":"87","author":"B Chaigne","year":"2022","unstructured":"Chaigne B, Tieu A, Beeker N, Zuelgaray E, Bouaziz JD, S\u00e8ne D et al (2022) Cluster analysis reveals eosinophilia and fibrosis as poor prognostic markers in 128 patients with eosinophilic fasciitis. J Am Acad Dermatol 87(5):997\u20131005. https:\/\/doi.org\/10.1016\/j.jaad.2022.08.026","journal-title":"J Am Acad Dermatol"},{"key":"7850_CR33","unstructured":"Wright DR, Haggins D, Chaffins M, Lokitz M (2009) Eosinophilic fasciitis versus morphea profunda: A spectrum of deep morphea. 67th Annual Meeting of the American Acacdemy of Dermatology: J Am Acad Dermatol"},{"key":"7850_CR34","doi-asserted-by":"publisher","first-page":"2050313x2412313","DOI":"10.1177\/2050313x241231384","volume":"12","author":"M Mihailescu","year":"2024","unstructured":"Mihailescu M, Abbas M (2024) A difficult diagnosis of eosinophilic fasciitis: a case report. SAGE Open Med Case Rep 12:2050313x241231384. https:\/\/doi.org\/10.1177\/2050313x241231384","journal-title":"SAGE Open Med Case Rep"},{"key":"7850_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jdcr.2025.01.012","volume":"58","author":"N Hewitt","year":"2025","unstructured":"Hewitt N, Tran K, Williams J, Bacaj P, Poling E, Zbehlik A (2025) Overlap of generalized morphea and eosinophilic fasciitis after recreational exposure to epoxy resin. JAAD Case Rep 58:29\u201332. https:\/\/doi.org\/10.1016\/j.jdcr.2025.01.012","journal-title":"JAAD Case Rep"},{"issue":"4","key":"7850_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40257-017-0269-x","volume":"18","author":"JS Mertens","year":"2017","unstructured":"Mertens JS, Seyger MMB, Thurlings RM, Radstake T, de Jong E (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol 18(4):491\u2013512. https:\/\/doi.org\/10.1007\/s40257-017-0269-x","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"7850_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000093847","volume":"213","author":"M Antic","year":"2006","unstructured":"Antic M, Lautenschlager S, Itin PH (2006) Eosinophilic fasciitis 30 years after - what do we really know? Report of 11 patients and review of the literature. Dermatology 213(2):93\u2013101. https:\/\/doi.org\/10.1159\/000093847","journal-title":"Dermatology"},{"issue":"2","key":"7850_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","volume":"64","author":"N Fett","year":"2011","unstructured":"Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64(2):217\u201328. https:\/\/doi.org\/10.1016\/j.jaad.2010.05.045. (quiz 29-30)","journal-title":"J Am Acad Dermatol"},{"key":"7850_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.05.023","author":"WJ Crisler","year":"2025","unstructured":"Crisler WJ, Rowley R, Oke O, Steuart SJ, Modi MM, Davis DL et al (2025) Eosinophilic Fasciitis and Morphea Share Gene Signatures of Inflammatory Cell Death, Self-DNA Recognition, and Enhanced Jak\/Signal Transducer and Activator of Transcription Signaling. J Invest Dermatol. https:\/\/doi.org\/10.1016\/j.jid.2025.05.023","journal-title":"J Invest Dermatol"},{"issue":"5","key":"7850_CR40","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/00000372-199510000-00007","volume":"17","author":"K Skobieranda","year":"1995","unstructured":"Skobieranda K, Helm KF (1995) Decreased expression of the human progenitor cell antigen (CD34) in morphea. Am J Dermatopathol 17(5):471\u2013475. https:\/\/doi.org\/10.1097\/00000372-199510000-00007","journal-title":"Am J Dermatopathol"},{"issue":"3","key":"7850_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1093\/rheumatology\/ker366","volume":"51","author":"D Lebeaux","year":"2012","unstructured":"Lebeaux D, Franc\u00e8s C, Barete S, Wechsler B, Dubourg O, Renoux J et al (2012) Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford) 51(3):557\u2013561. https:\/\/doi.org\/10.1093\/rheumatology\/ker366","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"7850_CR42","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/ijd.13940","volume":"57","author":"AF Nahhas","year":"2018","unstructured":"Nahhas AF, Alam M, Lim HW (2018) Rituximab as a therapeutic consideration for refractory eosinophilic fasciitis. Int J Dermatol 57(5):614\u2013615. https:\/\/doi.org\/10.1111\/ijd.13940","journal-title":"Int J Dermatol"},{"issue":"10","key":"7850_CR43","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s00296-021-04887-3","volume":"41","author":"N Kougkas","year":"2021","unstructured":"Kougkas N, Bertsias G, Papalopoulos I, Repa A, Sidiropoulos P, Avgoustidis N (2021) Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review. Rheumatol Int 41(10):1833\u20131837. https:\/\/doi.org\/10.1007\/s00296-021-04887-3","journal-title":"Rheumatol Int"},{"issue":"1","key":"7850_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.31138\/mjr.34.1.78","volume":"34","author":"S El Iskandarani","year":"2023","unstructured":"El Iskandarani S, Khasho M, Merashli M (2023) Tocilizumab in the treatment of eosinophilic fasciitis: a case study and review of literature. Mediterr J Rheumatol 34(1):78\u201385. https:\/\/doi.org\/10.31138\/mjr.34.1.78","journal-title":"Mediterr J Rheumatol"},{"issue":"4","key":"7850_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.clindermatol.2018.04.006","volume":"36","author":"N Fett","year":"2018","unstructured":"Fett N, Arthur M (2018) Eosinophilic fasciitis: current concepts. Clin Dermatol 36(4):487\u2013497. https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.006","journal-title":"Clin Dermatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07850-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07850-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T09:41:54Z","timestamp":1769679714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07850-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["7850"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07850-w","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written consent has been obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}